Search

Your search keyword '"Di Meo I"' showing total 85 results

Search Constraints

Start Over You searched for: Author "Di Meo I" Remove constraint Author: "Di Meo I"
85 results on '"Di Meo I"'

Search Results

1. Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

2. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

3. Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia

4. Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia

5. An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

6. Exploiting hiPSCs in Leber's Hereditary Optic Neuropathy (LHON): Present Achievements and Future Perspectives

10. Clinical, biochemical, and genetic features associated with VARS2-related mitochondrial disease

11. SURF1 knockout cloned pigs: Early onset of a severe lethal phenotype

13. Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications

14. AAV-mediated liver-specific MPV17 expression restores mtdna levels and prevents diet-induced liver failure

15. Altered Sulfide Metabolism in Ethylmalonic Encephalopathy

16. Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy.

17. The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs

18. Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary

19. Massive iron accumulation in PKAN-derived neurons and astrocytes: light on the human pathological phenotype

20. Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis

21. Exploiting hiPSCs in Leber's Hereditary Optic Neuropathy (LHON): Present Achievements and Future Perspectives

22. Adiponectin Role in Neurodegenerative Diseases: Focus on Nutrition Review

23. Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment

24. Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration

25. Clinical, biochemical, and genetic features associated with VARS2-related mitochondrial disease

26. Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways

27. Gene Therapy Using a Liver-targeted AAV Vector Restores Nucleoside and Nucleotide Homeostasis in a Murine Model of MNGIE

28. Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy

29. CoA synthase plays a critical role in neurodevelopment and neurodegeneration.

30. Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY-associated diseases.

31. Exploring the neuroprotective activity of a lignanamides-rich extract in human neuroblastoma SH-SY5Y cells under dimethyl sulfoxide-induced stress.

32. Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder.

33. Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia.

34. Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes.

35. Inherited Disorders of Coenzyme A Biosynthesis: Models, Mechanisms, and Treatments.

36. Mitochondrial Transplantation in Mitochondrial Medicine: Current Challenges and Future Perspectives.

37. Identification of Autophagy as a Functional Target Suitable for the Pharmacological Treatment of Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN) In Vitro.

38. PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes.

39. Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary.

40. Neurovascular coupling in patients with type 2 diabetes mellitus.

41. Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder.

42. Pathological mitophagy disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy.

43. Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective.

44. PKAN hiPS-Derived Astrocytes Show Impairment of Endosomal Trafficking: A Potential Mechanism Underlying Iron Accumulation.

45. An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model.

46. Massive iron accumulation in PKAN-derived neurons and astrocytes: light on the human pathological phenotype.

47. Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment.

48. Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis.

49. Novel deep intronic mutation in PLA2G6 causing early-onset Parkinson's disease with brain iron accumulation through pseudo-exon activation.

50. The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs.

Catalog

Books, media, physical & digital resources